The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This study compares mechanical sphincter augmentation (LINX Reflux Management System) to
double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to
gastroesophageal reflux disease (GERD).